Literature DB >> 20192927

Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis.

Vjollca Sahatciu-Meka1, Sylejman Rexhepi, Suzana Manxhuka-Kerliu, Mjellma Rexhepi.   

Abstract

Although considered a "joint disease," rheumatoid arthritis is associated with the involvement of extra-articular manifestations. The aim of the study is the investigation and comparison of frequency and type of extra-articular manifestations in a well defined community based cohort of patients with seropositive and seronegative rheumatoid arthritis. Using the ACR (1987) criteria for rheumatoid arthritis, patients have been classified into the 2nd and 3rd functional class (ARA). The studied group consisted of 125 seronegative patients with titters lower than 1:64 as defined by Rose-Waaler test, whereas the control group consisted of 125 seropositive patients with titters of 1:64 or higher. All patients were between 25-60 years of age (Xb=49,96), with disease duration between 1-27 years (Xb=6,41). In order to present the findings of the study, the structure, prevalence, arithmetic mean (Xb), standard deviation (SB), variation quotient (QV%) and variation interval (Rmax-Rmin) have been used. Probability level has been expressed by p<0,01 and p<0,05. Correlation between the number of extra-articular manifestations and duration of the disease has been calculated by means of Pearson linear correlation. Higher presence of diffuse lung fibrosis, central and peripheral nervous system damages have been confirmed in the seropositive group, and osteoporosis in the seronegative; however, no statistical difference has been found. In extra-articular manifestations, "rheumatoid core" in the seropositive subset (chi2=4,80, p<0,05) presented significant statistical difference. Rheumatoid nodules were more frequent in seropositive subset (12%:16%), in both sexes; however, they were not of significant statistical difference. Neuropathy and lung diseases were also frequently present in seropositive group, but no statistical difference has been found regarding the statistical difference. Longer duration of the disease resulted in an increase of the number of extra-articular manifestations. Calculated linear correlation by Pearson, resulted as positive and high correlation in total (r=0,36, p<0,01), and for groups [(r=0,52, p<0,01) seronegative, (r=0,25, p<0,01) seropositive], nevertheless no significant statistical difference was found regarding the sero-status. In conclusion, extra-articular manifestations are more frequent in the seropositive patients. The longer the duration of the disease the larger the number of extra-articular manifestations. Differences with regard to sero-status and sex, with some exceptions, are not observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192927      PMCID: PMC5596607          DOI: 10.17305/bjbms.2010.2729

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  31 in total

1.  [Detection of IgM rheumatoid factors using ELISA and agglutination tests with new latex].

Authors:  K Rosmus; D Sandow; B R Paulke; G Hellthaler; A Knak; C Becker; H Göhler; S Strube; K H Vogt
Journal:  Z Gesamte Hyg       Date:  1990-06

2.  Rheumatoid nodulosis: is it a different subset of rheumatoid arthritis?

Authors:  Irama Maldonado; Hala Eid; Graciela R Rodriguez; Oscar L Rillo; Jose A Barcat; Antonio J Reginato
Journal:  J Clin Rheumatol       Date:  2003-10       Impact factor: 3.517

3.  [Peripheral nerve entrapment syndrome of the upper extremities in cases of inflammatory, rheumatic joint diseases].

Authors:  F Kerschbaumer; G Y Kerschbaumer
Journal:  Z Rheumatol       Date:  2007-02       Impact factor: 1.372

4.  Clinical, laboratory, and radiographic features of rheumatoid arthritis with and without nodules.

Authors:  A Saraux; J Allain; C Guedes; I Valls; D Baron; P Youinou; P Le Goff
Journal:  Rev Rhum Engl Ed       Date:  1997-01

5.  Neuropathy in rheumatoid arthritis.

Authors:  M Y Nadkar; R Agarwal; R S Samant; S J Chhugani; S S Idgunji; S Iyer; N E Borges
Journal:  J Assoc Physicians India       Date:  2001-02

Review 6.  Rheumatoid pleural effusion.

Authors:  Alexandra Balbir-Gurman; Mordechai Yigla; Abraham Menahem Nahir; Yolanda Braun-Moscovici
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

7.  [Systemic rheumatoid arthritis].

Authors:  V Lilleby; J T Gran
Journal:  Tidsskr Nor Laegeforen       Date:  1997-11-30

8.  Diastolic heart function in RA patients.

Authors:  M Wislowska; B Jaszczyk; M Kochmański; S Sypuła; M Sztechman
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

9.  [Dot immunobinding assay for detection of three types of rheumatoid factor and its clinical significance].

Authors:  S Zhou
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  1993-08

10.  Lung involvement in rheumatoid factor-negative arthritis.

Authors:  O Scherak; G Kolarz; W Popp; A Wottawa; L Ritschka; O Braun
Journal:  Scand J Rheumatol       Date:  1993       Impact factor: 3.641

View more
  9 in total

1.  Pulmonary involvement in early rheumatoid arthritis patients.

Authors:  Hisham M Habib; Ashraf A Eisa; Waleed R Arafat; Mohamed A Marie
Journal:  Clin Rheumatol       Date:  2010-05-26       Impact factor: 2.980

2.  Cartilage oligomeric matrix protein - inflammation biomarker in knee osteoarthritis.

Authors:  Sandra Zivanović; Ljiljana Petrović Rackov; Aleksandar Zivanović; Milorad Jevtić; Sandra Nikolić; Sanja Kocić
Journal:  Bosn J Basic Med Sci       Date:  2011-02       Impact factor: 3.363

3.  A comparative study on the diversity of clinical features between the sero-negative and sero-positive rheumatoid arthritis patients.

Authors:  Yan Geng; Wei Zhou; Zhuo-Li Zhang
Journal:  Rheumatol Int       Date:  2011-12-24       Impact factor: 2.631

4.  Radiographic estimation in seropositive and seronegative rheumatoid arthritis.

Authors:  Vjollca Sahatçiu-Meka; Sylejman Rexhepi; Suzana Manxhuka-Kërliu; Mjellma Rexhepi
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

5.  Extra-articular Manifestations in Rheumatoid Arthritis.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie; R Tanasescu
Journal:  Maedica (Buchar)       Date:  2010-12

6.  The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis-A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study.

Authors:  Shan-Fu Yu; Jia-Feng Chen; Ying-Chou Chen; Yu-Wei Wang; Chung-Yuan Hsu; Han-Ming Lai; Hsiao-Ru He; Chi-Hua Ko; Wen-Chan Chiu; Tien-Tsai Cheng
Journal:  Front Med (Lausanne)       Date:  2022-06-09

7.  A cross-sectional study of association of serostatus and extra-articular manifestations in patients with rheumatoid arthritis in a teaching hospital.

Authors:  Bharat Kumar; Madhumita P Das; Arup Kumar Misra
Journal:  J Family Med Prim Care       Date:  2020-06-30

8.  Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report.

Authors:  Yutaka Kaneko; Takanori Murakami; Koichi Nishitsuka; Yuya Takakubo; Michiaki Takagi; Hidetoshi Yamashita
Journal:  Front Med (Lausanne)       Date:  2022-01-14

9.  Ocular Manifestations Related to Antibodies Positivity and Inflammatory Biomarkers in a Rheumatological Cohort.

Authors:  Carlos Cifuentes-González; Pilar Uribe-Reina; Juliana Reyes-Guanes; Juliana Muñoz-Ortiz; Paula Tatiana Muñoz-Vargas; William Rojas-Carabali; Dora Victoria Nova-Florián; Ana Sofía De-Los-Ríos; Rubén Dario Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2022-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.